Cannabinoids for use in the treatment of neuropathic pain
View Patent ↗The present invention relates to cannabinoids for use in the treatment of neuropathic pain. Preferably the cannabinoids are one or more phytocannabinoids of: cannabigerol (CBG), cannabichromene (CBC), cannabidivarin (CBDV) or tetrahydrocannabivarin (THCV). More preferably the phytocannabinoids are isolated and/or purified from cannabis plant extracts.
1. A method of treating a patient with neuropathic pain consisting essentially of administering to the patient an effective amount of cannabidivarin (CBDV) wherein the CBDV is of a purity of greater than 99% (w/w), or is produced synthetically and does not include cannabidiol (CBD) and/or tetrahydrocannabinol (THC).
2. The method as claimed in claim 1 , wherein the neuropathic pain is peripheral neuropathic pain.
3. The method as claimed in claim 2 , wherein the peripheral neuropathic pain is allodynia.
4. The method as claimed in claim 1 , wherein the CBDV is present in an effective human daily dose to relieve neuropathic pain.
5. The method as claimed in claim 4 , wherein the effective human daily dose of CBDV is between 5 mg and 100 mg.
6. The method as claimed in claim 5 , wherein the effective human daily dose of CBDV is between 10 mg and 50 mg.
7. The method as claimed in claim 1 , wherein the CBDV is packaged for use for an extended treatment period.
8. The method as claimed in claim 7 , wherein the extended treatment period is at least 7 days.
9. The method as claimed in claim 1 , wherein the CBDV is administered to the patient in combination with one or more other medicinal substances used in the treatment of neuropathic pain.